S 2837
115th Congress
Senate
Crime and Law Enforcement
Administrative law and regulatory procedures
Business records
Civil actions and liability
Congressional oversight
Criminal investigation, prosecution, interrogation
Criminal justice information and records
Department of Justice
Drug trafficking and controlled substances
Intergovernmental relations
Licensing and registrations
Retail and wholesale trades
State and local government operations
Preventing Drug Diversion Act of 2018
Introduced: May 14, 2018
Introduced by:
Hassan, Margaret Wood
Democratic
· New Hampshire
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 19, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 471.
Jun 19, 2018
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Jun 14, 2018
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
May 14, 2018
Read twice and referred to the Committee on the Judiciary.
May 14, 2018
Introduced in Senate
Plain-English summary
Preventing Drug Diversion Act of 2018
This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion.
Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.
Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 471.
Committees of jurisdiction
1
Cosponsors
1